GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs GlaxoSmithKline and Chroma Therapeutics Limited announced a collaboration to develop macrophage-targeted compounds using Chroma's proprietary esterase-sensitive motif technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process. [more...]
